Mechanisms of phospholipase C activation by the vasoactive intestinal polypeptide/pituitary adenylate cyclase activating polypeptide type 2 receptor

C. MacKenzie, E. Lutz, M.S. Johnson, D.N. Robertson, P.J. Holland, R. Mitchell

Research output: Contribution to journalArticle

29 Citations (Scopus)

Abstract

The vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide type 2 (VPAC2) receptor was shown to induce both [3H]inositol phosphate ([3H]InsP)and cAMP production in transfected COS7 cells and in GH3 cells where it is natively expressed. Neither cholera toxin nor forskolin could elicit an equivalent [3H]InsP response, suggesting independent coupling of the two pathways. The VPAC2 receptor-mediated [3H]InsP response was partially inhibited by pertussis toxin (Ptx) and by the G{beta}{gamma}-sequestering C-terminal fragment of GRK2 (GRK2-ct) in COS7 and GH3 cells, whereas responses of control receptors were unaffected. Blockers of receptor-activated Ca2+ influx pathways (Co2+ and SKF 96365) also partially inhibited VPAC2 receptor-mediated [3H]InsP responses. This inhibition was not present in the component of the response remaining after Ptx treatment. A range of blockers of voltage-sensitive Ca2+ channels were ineffective, consistent with the reported lack of these channels in COS7 cells. The data suggest that the VPAC2 receptor may couple to phospholipase C through both Ptx-insensitive and Ptx-sensitive G proteins (Gq/11 and Gi/o, respectively) to generate [3H]InsP. In addition to G{beta}{gamma}, Gi/o activation appears to require receptor-activated Ca2+ entry. This is consistent with the possibility that not only G{alpha}q/11-responsive and G{beta}{gamma}-responsive isoforms of phospholipase C but also Ca2+-responsive forms may contribute to the overall [3H]InsP response.
Original languageEnglish
Pages (from-to)1209-1217
Number of pages8
JournalEndocrinology
Volume142
Issue number3
Publication statusPublished - 2001

Keywords

  • endocrinology
  • biomedical science
  • physiology
  • polypeptide
  • disease
  • immunology

Cite this

MacKenzie, C., Lutz, E., Johnson, M. S., Robertson, D. N., Holland, P. J., & Mitchell, R. (2001). Mechanisms of phospholipase C activation by the vasoactive intestinal polypeptide/pituitary adenylate cyclase activating polypeptide type 2 receptor. Endocrinology, 142(3), 1209-1217.